Publications, Pharmaceutical

Moving Toward a More Sustainable Future With pMDIs

It is now more than half a century since patients were introduced to the pressurized metered dose inhaler (pMDI) as a convenient, effective vehicle for the symptomatic relief and sustained management of conditions such as Asthma and Chronic Obstructive Pulmonary Disease (COPD).

Download Publication
Author(s): Chris Baron
Drug Development and Delivery
1 Jul 2021

This innovation has since become a dominant drug-delivery device for Asthma and COPD patients, helping millions of people around the world. Recent history has also seen us better understand how human activities can negatively impact our planet, which includes growing evidence of the causal link between increasing levels of atmospheric carbon dioxide and rising global temperatures.

Back To Top